| Year |
Citation |
Score |
| 2015 |
Kalantari-Dehaghi M, Parnell EA, Armand T, Bernard HU, Grando SA. The nicotinic acetylcholine receptor-mediated reciprocal effects of the tobacco nitrosamine NNK and SLURP-1 on human mammary epithelial cells. International Immunopharmacology. 29: 99-104. PMID 25986726 DOI: 10.1016/J.Intimp.2015.04.041 |
0.572 |
|
| 2015 |
Kalantari M, Bernard HU. Assessment of the HPV DNA methylation status in cervical lesions. Methods in Molecular Biology (Clifton, N.J.). 1249: 267-80. PMID 25348313 DOI: 10.1007/978-1-4939-2013-6_20 |
0.395 |
|
| 2014 |
Kalantari M, Osann K, Calleja-Macias IE, Kim S, Yan B, Jordan S, Chase DM, Tewari KS, Bernard HU. Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia. Virology. 448: 314-21. PMID 24314662 DOI: 10.1016/J.Virol.2013.10.032 |
0.442 |
|
| 2012 |
Parnell EA, Calleja-Macias IE, Kalantari M, Grando SA, Bernard HU. Muscarinic cholinergic signaling in cervical cancer cells affects cell motility via ERK1/2 signaling. Life Sciences. 91: 1093-8. PMID 22406505 DOI: 10.1016/J.Lfs.2012.02.020 |
0.587 |
|
| 2012 |
Calleja-Macias I, Osann K, Remedios-Chan M, Barrera-Saldana HA, Illades-Aguiar B, Anton-Culver H, Chikova AK, Grando SA, Bernard HU. Association of single nucleotide polymorphisms of nicotinic acetylcholine receptor subunits with cervical neoplasia. Life Sciences. 91: 1099-102. PMID 22406075 DOI: 10.1016/J.Lfs.2012.02.015 |
0.451 |
|
| 2012 |
Kalantari-Dehaghi M, Bernard HU, Grando SA. Reciprocal effects of NNK and SLURP-1 on oncogene expression in target epithelial cells. Life Sciences. 91: 1122-5. PMID 22369755 DOI: 10.1016/J.Lfs.2012.02.004 |
0.437 |
|
| 2012 |
Chikova A, Bernard HU, Shchepotin IB, Grando SA. New associations of the genetic polymorphisms in nicotinic receptor genes with the risk of lung cancer. Life Sciences. 91: 1103-8. PMID 22280835 DOI: 10.1016/J.Lfs.2011.12.023 |
0.375 |
|
| 2010 |
Luevano M, Bernard HU, Barrera-Saldaña HA, Trevino V, Garcia-Carranca A, Villa LL, Monk BJ, Tan X, Davies DH, Felgner PL, Kalantari M. High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays. Virology. 405: 31-40. PMID 20554302 DOI: 10.1016/j.virol.2010.05.011 |
0.331 |
|
| 2010 |
Kalantari M, Chase DM, Tewari KS, Bernard HU. Recombination of human papillomavirus-16 and host DNA in exfoliated cervical cells: a pilot study of L1 gene methylation and chromosomal integration as biomarkers of carcinogenic progression. Journal of Medical Virology. 82: 311-20. PMID 20029805 DOI: 10.1002/Jmv.21676 |
0.366 |
|
| 2010 |
Willner J, Chase D, Kalantari M, Osann K, Wenzel L, Bernard H, Tewari K. Human papillomavirus-16 L1 gene methylation as a biomarker for progression of cervical intraepithelial lesions Gynecologic Oncology. 116: 593. DOI: 10.1016/J.Ygyno.2009.10.003 |
0.363 |
|
| 2009 |
Calleja-Macias IE, Kalantari M, Bernard HU. Cholinergic signaling through nicotinic acetylcholine receptors stimulates the proliferation of cervical cancer cells: an explanation for the molecular role of tobacco smoking in cervical carcinogenesis? International Journal of Cancer. Journal International Du Cancer. 124: 1090-6. PMID 19048619 DOI: 10.1002/Ijc.24053 |
0.48 |
|
| 2008 |
Kalantari M, Villa LL, Calleja-Macias IE, Bernard HU. Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation. International Journal of Cancer. 123: 1832-40. PMID 18688866 DOI: 10.1002/Ijc.23707 |
0.439 |
|
| 2008 |
Kalantari M, Lee D, Calleja-Macias IE, Lambert PF, Bernard HU. Effects of cellular differentiation, chromosomal integration and 5-aza-2'-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines. Virology. 374: 292-303. PMID 18242658 DOI: 10.1016/J.Virol.2007.12.016 |
0.42 |
|
| 2007 |
Balderas-Loaeza A, Anaya-Saavedra G, Ramirez-Amador VA, Guido-Jimenez MC, Kalantari M, Calleja-Macias IE, Bernard HU, Garcia-Carranca A. Human papillomavirus-16 DNA methylation patterns support a causal association of the virus with oral squamous cell carcinomas. International Journal of Cancer. 120: 2165-9. PMID 17278110 DOI: 10.1002/ijc.22563 |
0.3 |
|
| 2007 |
Turan T, Kalantari M, Cuschieri K, Cubie HA, Skomedal H, Bernard HU. High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia. Virology. 361: 185-93. PMID 17175003 DOI: 10.1016/J.Virol.2006.11.010 |
0.375 |
|
| 2006 |
Turan T, Kalantari M, Calleja-Macias IE, Cubie HA, Cuschieri K, Villa LL, Skomedal H, Barrera-Saldaña HA, Bernard HU. Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression? Virology. 349: 175-83. PMID 16472835 DOI: 10.1016/J.Virol.2005.12.033 |
0.412 |
|
| 2006 |
Bernard HU, Calleja-Macias IE, Dunn ST. Genome variation of human papillomavirus types: phylogenetic and medical implications. International Journal of Cancer. 118: 1071-6. PMID 16331617 DOI: 10.1002/Ijc.21655 |
0.435 |
|
| 2005 |
Calleja-Macias IE, Villa LL, Prado JC, Kalantari M, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE, Dunn ST, Chu TY, Cubie HA, Cuschieri K, von Knebel-Doeberitz M, Martins CR, ... ... Bernard HU, et al. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. Journal of Virology. 79: 13630-40. PMID 16227283 DOI: 10.1128/JVI.79.21.13630-13640.2005 |
0.312 |
|
| 2005 |
Prado JC, Calleja-Macias IE, Bernard HU, Kalantari M, Macay SA, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE, Dunn ST, Ortiz-Lopez R, Barrera-Saldaña HA, Cubie HA, Cuschieri K, et al. Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18. Virology. 340: 95-104. PMID 16039686 DOI: 10.1016/j.virol.2005.06.024 |
0.314 |
|
| 2005 |
Wiley DJ, Huh J, Rao JY, Chang C, Goetz M, Poulter M, Masongsong E, Chang CI, Bernard HU. Methylation of human papillomavirus genomes in cells of anal epithelia of HIV-infected men. Journal of Acquired Immune Deficiency Syndromes (1999). 39: 143-51. PMID 15905729 |
0.302 |
|
| 2005 |
Smialowski P, Singh M, Mikolajka A, Majumdar S, Joy JK, Nalabothula N, Krajewski M, Degenkolbe R, Bernard HU, Holak TA. NMR and mass spectrometry studies of putative interactions of cell cycle proteins pRb and CDK6 with cell differentiation proteins MyoD and ID-2. Biochimica Et Biophysica Acta. 1750: 48-60. PMID 15878699 DOI: 10.1016/J.Bbapap.2005.03.012 |
0.314 |
|
| 2005 |
Calleja-Macias IE, Kalantari M, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE, Dunn ST, Ortiz-Lopez R, Barrera-Saldaña HA, Cubie HA, Cuschieri K, Villa LL, Bernard HU. Papillomavirus subtypes are natural and old taxa: Phylogeny of human papillomavirus types 44 and 55 and 68a and -b Journal of Virology. 79: 6565-6569. PMID 15858044 DOI: 10.1128/JVI.79.10.6565-6569.2005 |
0.304 |
|
| 2005 |
Bernard HU. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 32: S1-6. PMID 15753006 DOI: 10.1016/J.Jcv.2004.10.021 |
0.434 |
|
| 2004 |
Kalantari M, Calleja-Macias IE, Tewari D, Hagmar B, Lie K, Barrera-Saldana HA, Wiley DJ, Bernard HU. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. Journal of Virology. 78: 12762-72. PMID 15542628 DOI: 10.1128/Jvi.78.23.12762-12772.2004 |
0.412 |
|
| 2004 |
Badal S, Badal V, Calleja-Macias IE, Kalantari M, Chuang LS, Li BF, Bernard HU. The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology. 324: 483-92. PMID 15207633 DOI: 10.1016/J.Virol.2004.04.002 |
0.457 |
|
| 2004 |
Calleja-Macias IE, Kalantari M, Huh J, Ortiz-Lopez R, Rojas-Martinez A, Gonzalez-Guerrero JF, Williamson AL, Hagmar B, Wiley DJ, Villarreal L, Bernard HU, Barrera-Saldaña HA. Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants Virology. 319: 315-323. PMID 14980491 DOI: 10.1016/J.Virol.2003.11.009 |
0.418 |
|
| 2003 |
Gupta S, Takhar PP, Degenkolbe R, Koh CH, Zimmermann H, Yang CM, Guan Sim K, Hsu SI, Bernard HU. The human papillomavirus type 11 and 16 E6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br1. Virology. 317: 155-64. PMID 14675634 DOI: 10.1016/J.Virol.2003.08.008 |
0.43 |
|
| 2003 |
Badal V, Chuang LS, Tan EH, Badal S, Villa LL, Wheeler CM, Li BF, Bernard HU. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. Journal of Virology. 77: 6227-34. PMID 12743279 DOI: 10.1128/Jvi.77.11.6227-6234.2003 |
0.471 |
|
| 2003 |
Tan SH, Baker CC, Stünkel W, Bernard HU. A transcriptional initiator overlaps with a conserved YY1 binding site in the long control region of human papillomavirus type 16. Virology. 305: 486-501. PMID 12573593 DOI: 10.1006/Viro.2002.1779 |
0.417 |
|
| 2002 |
Bernard HU. Gene expression of genital human papillomaviruses and considerations on potential antiviral approaches. Antiviral Therapy. 7: 219-37. PMID 12553476 |
0.367 |
|
| 2000 |
Stünkel W, Huang Z, Tan S, O'Connor MJ, Bernard H. Nuclear Matrix Attachment Regions of Human Papillomavirus Type 16 Repress or Activate the E6 Promoter, Depending on the Physical State of the Viral DNA Journal of Virology. 74: 2489-2501. PMID 10684263 DOI: 10.1128/Jvi.74.6.2489-2501.2000 |
0.447 |
|
| 2000 |
O'Connor MJ, Stünkel W, Koh C, Zimmermann H, Bernard H. The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element. Journal of Virology. 74: 401-410. DOI: 10.1128/Jvi.74.1.401-410.2000 |
0.457 |
|
| 1999 |
Zimmermann H, Degenkolbe R, Bernard H, O’Connor MJ. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. Journal of Virology. 73: 6209-6219. PMID 10400710 DOI: 10.1128/Jvi.73.8.6209-6219.1999 |
0.404 |
|
| 1999 |
Stünkel W, Bernard H. The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. Journal of Virology. 73: 1918-1930. PMID 9971771 DOI: 10.1128/Jvi.73.3.1918-1930.1999 |
0.417 |
|
| 1998 |
O’Connor MJ, Stünkel W, Zimmermann H, Koh C, Bernard H. A Novel YY1-Independent Silencer Represses the Activity of the Human Papillomavirus Type 16 Enhancer Journal of Virology. 72: 10083-10092. PMID 9811748 DOI: 10.1128/Jvi.72.12.10083-10092.1998 |
0.413 |
|
| 1992 |
Tan Sh, Gloss B, Bernard Hu. During negative regulation of the human papillomavirus-16E6 promoter, the viral E2 protein can displace SP1 from a proximal promoter element Nucleic Acids Research. 20: 251-256. PMID 1311070 DOI: 10.1093/Nar/20.2.251 |
0.323 |
|
| 1991 |
Chong T, Apt D, Gloss B, Isa M, Bernard H. The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription. Journal of Virology. 65: 5933-5943. PMID 1656080 DOI: 10.1128/Jvi.65.11.5933-5943.1991 |
0.446 |
|
| 1990 |
Chong T, Chan W, Bernard H. Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers Nucleic Acids Research. 18: 465-470. PMID 2155400 DOI: 10.1093/Nar/18.3.465 |
0.382 |
|
| Show low-probability matches. |